Larvol Delta - REcovery-and-SURvival-of-patients-with-moderate-to-severe-acute-REspiratory-distress-syndrome-ARDS-due-to-COVID19-a-multicenter-singlearm-Phase-IV-itolizumab-Trial-RESURRECT

Alzumab (itolizumab) - Biocon, Equillium, Ono Pharma

http://www.ncbi.nlm.nih.gov/pubmed/37073744

Apr 19, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next